BREAKING
Rambus Inc. Jumps 6.3% 3 hours ago Clear Secure, Inc. Drops 6.1% in Broad Selloff 3 hours ago DigitalOcean Holdings, Inc. Drops 7.2% in Broad Selloff 22 hours ago CleanSpark, Inc. (CLSK) Jumps 5.2% to $10.39 22 hours ago Warrior Met Coal Drops 5.3% Amid Sector-Wide Selling 22 hours ago Peabody Energy Corporation Drops 6.1% in Broad Selloff 23 hours ago CVR Energy Stock Drops 7.5% Amid Sector-Wide Selling 23 hours ago Palomar Holdings, Inc. (PLMR) Jumps 4.7% to $134.46 24 hours ago Core Natural Resources Drops 5.7% Amid Sector-Wide Selling 24 hours ago Ultra Clean Holdings, Inc. Jumps 5.4% 24 hours ago Rambus Inc. Jumps 6.3% 3 hours ago Clear Secure, Inc. Drops 6.1% in Broad Selloff 3 hours ago DigitalOcean Holdings, Inc. Drops 7.2% in Broad Selloff 22 hours ago CleanSpark, Inc. (CLSK) Jumps 5.2% to $10.39 22 hours ago Warrior Met Coal Drops 5.3% Amid Sector-Wide Selling 22 hours ago Peabody Energy Corporation Drops 6.1% in Broad Selloff 23 hours ago CVR Energy Stock Drops 7.5% Amid Sector-Wide Selling 23 hours ago Palomar Holdings, Inc. (PLMR) Jumps 4.7% to $134.46 24 hours ago Core Natural Resources Drops 5.7% Amid Sector-Wide Selling 24 hours ago Ultra Clean Holdings, Inc. Jumps 5.4% 24 hours ago
ADVERTISEMENT
REGN

Regeneron Pharmaceuticals Inc

$REGN NASDAQ Apr 8, 2026 All Day

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

REGN Coverage

Event Regeneron Pharmaceuticals Inc (REGN) Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions Apr 2, 2026 Event Regeneron Pharmaceuticals Inc (REGN) TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions Apr 2, 2026 Event Regeneron Pharmaceuticals Inc (REGN) EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) Apr 2, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Transcript Feb 2, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7% May 4, 2023 Press Release Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31% Feb 3, 2023